Growth and health of Holstein calves fed milk replacers supplemented with antibiotics or Enteroguard.
Forty-five Holstein calves were fed milk replacers containing either antibiotics [MRA (oxytetracycline at 138 mg/kg and neomycin at 276 mg/kg), n = 22)] or Enteroguard [MRE, a blend of fructooligosaccharides, allicin, and gut-active microbes at (129 mg/kg, n = 23)] from birth to 5 wk of age to compare effects on average daily gain and on incidence of scours. Performance was evaluated by measuring weight gain, feed efficiency, and fecal scores. The overall body weight gains and severity of scours were not different between treatments, nor were there differences in starter intake or mean body weight gain. During wk 2, the average gain of calves fed MRA was less than that of calves fed MRE (0.07 vs. 0.09 kg/d, P = 0.09), and greater during wk 5 (0.62 vs. 0.51 kg/d, P < 0.01); however, total gain for calves fed MRE was not different from calves fed MRA. Likewise, average feed efficiencies (gain/dry matter intake) were not different. Severity of scours, as measured by fecal scores, and concentrations of serum proteins, an indirect measure of immunoglobulins, were similar for calves fed MRA and MRE. The results suggest that antibiotics in milk replacers can be replaced with compounds such as fructooligosaccharides, probiotics, and allicin to obtain similar calf performance.
Donovan
D C
DC
Department of Dairy Science, South Dakota State University, Brookings 57007-0647, USA.
Franklin
S T
ST
Chase
C C L
CC
Hippen
A R
AR
D000821:Animal Feed; D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development / Q000502:physiology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000890:Anti-Infective Agents / Q000008:administration & dosage; D002417:Cattle / Q000254:growth & development* / Q000502:physiology; D003967:Diarrhea / Q000453:epidemiology / Q000662:veterinary; D004220:Disulfides; D005243:Feces; D005260:Female; D005526:Food, Formulated; D015994:Incidence; D008297:Male; D009355:Neomycin / Q000008:administration & dosage; D009844:Oligosaccharides / Q000008:administration & dosage*; D010118:Oxytetracycline / Q000008:administration & dosage; D019936:Probiotics / Q000008:administration & dosage*; D011897:Random Allocation; D013441:Sulfinic Acids / Q000008:administration & dosage*; D015430:Weight Gain
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004220:Disulfides; D009844:Oligosaccharides; D013441:Sulfinic Acids; C116580:fructooligosaccharide; C006452:allicin; D009355:Neomycin; D010118:Oxytetracycline